182564-41-6Relevant articles and documents
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide
Choi, Seok-Ki,Green, David,Ho, Anne,Klein, Uwe,Marquess, Daniel,Taylor, Robert,Turner, S. Derek
supporting information; experimental part, p. 3609 - 3616 (2009/04/07)
We demonstrate here that covalent dimerization of 5-HT1 ligands is an effective design strategy to modulate affinity and selectivity of 5-HT1 ligands. This approach was applied to LY-334370, a selective agonist of 5-HT1F r
METHODS OF TREATING OR AMELIORATING THE SYMPTOMS OF COMMON COLD OR ALLERGIC RHINITIS WITH SEROTONIN 5-HT1F
-
, (2008/06/13)
This invention provides methods for the treatment or amelioration of the symptoms of the common cold or allergic rhinitis which comprises administering to a mammal in need thereof a serotonin 5-HT 1F agonist.
5-SUBSTITUTED-3-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)-AND 3-(PIPERIDIN-4-YL)-1H-INDOLES: NEW 5-HT1F AGONISTS
-
, (2008/06/13)
This invention provides novel 5-HT 1F agonists of Formula I STR1 where A--B, R, R 1 and X are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
Use of serotonin 5-HT1F agonists for the prevention of migraine
-
, (2008/06/13)
This invention provides methods for the prevention of migraine which comprises administering to a mammal in need thereof a serotonin 5-HT1F agonist.
Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
-
, (2008/06/13)
This invention provides methods for the treatment or amelioration of the symptoms of the common cold or allergic rhinitis which comprises administering to a mammal in need thereof a serotonin 5-HT1F agonist.